Enzyme vs DefiTuna — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while DefiTuna trades at Rp74.46 (market cap --, Rp85,25jt 24h volume). The key difference: Enzyme's circulating supply is 3,3M MLN versus -- for DefiTuna, and Enzyme is more actively traded (Rp104,56M versus Rp85,25jt). Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and DefiTuna for 9 Days on average.
| MLN | TUNA | |
|---|---|---|
Market Cap | Rp134,13M | -- |
Volume (24h) | Rp104,56M | Rp85,25jt |
Circulating Supply | 3,3M MLN | -- |
Typical Hold Time | 29 Days | 9 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
DefiTuna shows limited market data availability with unknown current price and market cap. The token has a maximum supply of 1M TUNA and exhibits a relatively short average hold time of 9 days, suggesting active trading. Technical analysis reveals the asset lacks recent price and volume data, making trend assessment challenging.
Outlook remains speculative due to data gaps. Key opportunities include potential price discovery if exchange listings expand, while major risks include extreme volatility from low liquidity and regulatory uncertainty in the Indonesian crypto market. Investors should approach with caution given the limited verifiable metrics.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →DefiTuna is a DeFi infrastructure layer for leveraged liquidity on Solana. Now powered by Fusion AMM—an on-chain model combining concentrated liquidity and transparent limit orders—it unifies lending, leverage, and AMMs to enable capital-efficient trading and liquidity strategies.
Read more on TUNA →